1982
DOI: 10.1136/thx.37.1.68
|View full text |Cite
|
Sign up to set email alerts
|

Plasma concentrations of lignocaine during fibreoptic bronchoscopy.

Abstract: Peak plasma concentrations of lignocaine were recorded in 41 patients receiving topically applied lignocaine for fibreoptic bronchoscopy. Adequate anaesthesia was achieved in all patients with an average dose per unit weight of 9 3 + 0 5 mg/kg (SEM) giving a mean peak plasma concentration of 2-9 + 0.5 mg/1-1 (SEM) (± SE 0.5). The plasma concentration exceeded toxic levels of 5.0 mg/l-1 in only two patients, and no complications were observed. Peak concentrations were influenced only by dose per unit weight adm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
58
1
1

Year Published

1989
1989
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(64 citation statements)
references
References 10 publications
4
58
1
1
Order By: Relevance
“…For ETL dosage in our study we used 1 mg/kg of lidocaine while Groeben et al [25] used 5 mg/kg and had a lidocaine plasma concentration of 1.5 ± 0.14 μg/mL, that suggests that the level of lidocaine in our patients' plasma was lower than 1.5 μg/mL. There are conflicting views in studies regarding maximum safe doses of local anesthetic drugs [30][31][32][33]. There was direct correlation between pharmacological effect of lidocaine [30,31] and blood concentration of lidocaine in arterial plasma at which symptoms of local anesthetic toxicity were evident ranging from 2.0 to 6.0 μg/mL [34].…”
Section: Discussionmentioning
confidence: 85%
“…For ETL dosage in our study we used 1 mg/kg of lidocaine while Groeben et al [25] used 5 mg/kg and had a lidocaine plasma concentration of 1.5 ± 0.14 μg/mL, that suggests that the level of lidocaine in our patients' plasma was lower than 1.5 μg/mL. There are conflicting views in studies regarding maximum safe doses of local anesthetic drugs [30][31][32][33]. There was direct correlation between pharmacological effect of lidocaine [30,31] and blood concentration of lidocaine in arterial plasma at which symptoms of local anesthetic toxicity were evident ranging from 2.0 to 6.0 μg/mL [34].…”
Section: Discussionmentioning
confidence: 85%
“…The maximum lidocaine level was found to be 3.79 μg/ml in a patient with hepatic metastases who only received 420 mg topical lidocaine (LeLorier et al, 1979). A follow-up study in 1982 by Efthimiou et al of 41 FOB patients used a similar mean lidocaine dose (9.3 ± 0.5 mg/kg); mean peak levels were 2.9 ± 0.5 μg/ml and two patients had a lidocaine level > 5 μg/ml with no complications (Efthimiou et al, 1982). Ameer et al compared an elderly group of 14 patients (mean age of 67 years) with a young group of five patients (mean age of 42 years).…”
Section: Dosing Of Topical Anesthesiamentioning
confidence: 99%
“…These studies evaluating lidocaine dosing have been done to evaluate a variety of techniques in application of topical anesthesia (Ameer et al, 1989;Amitai et al, 1990, Berger et al, 1989Boye & Bresden, 1979;Efthimiou et al, 1982;Gjonaj et al, 1997;Gomez et al, 1983;Jones et al, 1982;Karvonen et al, 1976;Korttila et al, 1981;Langmack et al, 2000;Le Lorier et al, 1979;Loukides et al, 2000;Mainland et al, 2001;McBurney et al, 1984;Milman et al, 1998;Patterson et al, 1975;Smith et al, 1985;Sucena et al, 2004;Sutherland et al, 1985). These twenty studies were reviewed by Frey et al in their study of lidocaine dosing (Frey et al, 2008).…”
Section: Dosing Of Topical Anesthesiamentioning
confidence: 99%
“…14 Earlier studies showed that most patients have a peak plasma concentration well below the toxic level even with high doses of topical lidocaine, 15,16 so the relationship between seizure and topical lidocaine is considered to be obscure. Because the total dose of topical anesthesia was 500 mg (9.7 mg/kg), it is probable that the high dose induced her cardiac event or seizures.…”
Section: Flexible Bronchoscopy-induced Takotsubo Cardiomyopathy E152mentioning
confidence: 99%